Ibrutinib dose intensity in high‐risk chronic lymphocytic leukemia
Gabriela Forestieri(Institute of Oncology Research), Adalgisa Condoluci(Ente Ospedaliero Cantonale), Alessandra Tedeschi(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Francesco Passamonti(University of Milan), Lodovico Terzi di Bergamo(Institute of Oncology Research), Georg Stüssi(Institute of Oncology Research), Davide Rossi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Daniela Gussetti(Centro di Riferimento Oncologico), Maria Cristina Pirosa(Institute of Oncology Research), Joyce Marques de Almeida(Institute of Oncology Research), Marina Deodato(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Riccardo Moia(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Francesco Autore(Agostino Gemelli University Polyclinic), Pietro Bulian(Centro di Riferimento Oncologico), Luca Laurenti(Sapienza University of Rome), Lydia Scarfò(IRCCS Ospedale San Raffaele), Deborah Piffaretti(Institute of Oncology Research), Gianluca Gaïdano(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Franco Cavalli(Institute of Social and Preventive Medicine), Katia Pini(Institute of Oncology Research), Annagiulia Zanatta(Centro di Riferimento Oncologico), Silvia Rasi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Matin Salehi(SIB Swiss Institute of Bioinformatics), B. Gerber(University of Zurich), Michele Merli(University of Insubria), Anna Maria Frustaci(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Valter Gattei(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Gaby Fahrni(University of Lucerne), Clara Deambrogi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Roberta Mattarucchi(University of Insubria), Paolo Ghia(Vita-Salute San Raffaele University), Emanuele Zucca(Università della Svizzera italiana), Michael Gregor(University of Lucerne), Alessio Bruscaggin(Institute of Oncology Research), Valeria Spina(Ente Ospedaliero Cantonale), Jakob Passweg(University Hospital of Basel)
Cited by 2
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Solid Cancers after Bone Marrow Transplantation
|New England Journal of Medicine|1997|968